CRS: BJMC
Position: Lab Manager
Position: TB Laboratory Coordinator
CRS:
Position:
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
